BioNTech SE (BNTX) Finished Goods (2018 - 2021)
BioNTech SE (BNTX) reported Finished Goods of $194.1 million for Q4 2021, up 40605.68% on a YoY basis from N/an in Q4 2020, and up 40605.68% sequentially from $476915.9 in Q4 2020.
BioNTech SE (BNTX) Finished Goods (2018 - 2021) Analysis & Trends
BioNTech SE (BNTX) has 4 years of Finished Goods data on file, last reported at $194.1 million in Q4 2021.
- For the quarter ending Q4 2021, Finished Goods rose 40605.68% year-over-year to $194.1 million; the trailing twelve-month figure through Dec 2021 stood at $194.1 million (up 40605.68% YoY), and the FY2021 full-year result was $200.8 million, up 43871.6% from the prior year.
- Finished Goods grew to $194.1 million in Q4 2021, from $476915.9 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $194.1 million in Q4 2021 to a low of $476915.9 in Q4 2020.
- A 4-year average of $49.2 million and a median of $1.1 million in 2018 frame the typical range for Finished Goods.
- Across the five-year window, Finished Goods tumbled 50.25% in 2019 and jumped 40605.68% in 2021, its largest moves.
- Tracing BNTX's Finished Goods over 4 years: stood at $1.4 million in 2018, then plunged by 50.25% to $700659.9 in 2019, then sank by 31.93% to $476915.9 in 2020, then jumped by 40605.68% to $194.1 million in 2021.
- Business Quant data shows BNTX's Finished Goods at $194.1 million in Q4 2021, $476915.9 in Q4 2020, and $700659.9 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 194.13 Mn |
| Dec 31, 2020 | 476,915.94 |
| Dec 31, 2019 | 700,659.90 |
| Dec 31, 2018 | 1.41 Mn |